Incremental Healthcare Cost Implications of Retreatment Following Ureteroscopy or Percutaneous Nephrolithotomy for Upper Urinary Tract Stones: A Population-Based Study of Commercially-Insured US Adults.
Stephen S JohnstonBrian Po-Han ChenPragya RaiPhilippe GrangeHarikumaran R DwarakanathanTony AmosBarbara H JohnsonSudip K GhoshNoor BuchholzPublished in: Medical devices (Auckland, N.Z.) (2022)
Retreatment during the first year following URS or PCNL was needed in 23% and 36% of patients, respectively, and was associated with an economic burden of up to $23,500 per patient. The high rate of retreatment and associated costs demonstrate there is an unmet need to improve mid- to long-term results in URS and PCNL.